Home›Companies›Healthcare›Ellipsys Medical

Ellipsys Medical, Inc.

Makes a device physicians use to create dialysis access for patients with kidney failure.

Updated Nov 9, 2026·Latest SEC filing Oct 14, 2026·Suggest an edit

About Ellipsys Medical

Ellipsys Medical is a private company based in San Clemente, California, incorporated in 2026 in Delaware. It has reported $8,572,950 raised in one offering on Form D since September 2026. Its chief executive is Brian Driscoll.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 22, 2026Sep 8, 2026amended Oct 14, 2026$8,572,950of $10.8M target91$94,208EquityRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ellipsys Medical's Form D filed Oct 14, 2026.

FH
Frank Hettmann
President and director
EC
Ed Chang
Director
Also a director at Aveera Medical.
MR
Mark Ritchart
Director
Also a director at Aveera Medical.
SP
Steve Parker
Director
Also a director at Aveera Medical.
JH
Jeffrey Hull
Director
Also a director at Aveera Medical.
BD
Brian Driscoll
CEO and director
Also a president at Aveera Medical.

Sources

  1. SECEllipsys Medical, Inc. Form D/A, filed Sep 29, 2026
  2. SECEllipsys Medical, Inc. Form D/A, filed Sep 17, 2026
  3. SECEllipsys Medical, Inc. Form D, filed Sep 8, 2026
  4. SECEllipsys Medical, Inc. filing history
  5. PressEllipsys Medical product announcement